These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3084691)

  • 1. Antihemophilic factor [factor VIII] preparations inhibit lymphocyte proliferation and production of interleukin-2.
    Lederman MM; Saunders C; Toossi Z; Lemon N; Everson B; Ratnoff OD
    J Lab Clin Med; 1986 May; 107(5):471-8. PubMed ID: 3084691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human T lymphocyte proliferation in vitro by commercial factor VIII concentrates.
    Wang Y; Beck EA; Furlan M; de Weck AL
    Vox Sang; 1985; 48(6):343-9. PubMed ID: 3925631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of interleukin-2 secretion by factor VIII concentrates: a possible cause of immunosuppression in haemophiliacs.
    Thorpe R; Dilger P; Dawson NJ; Barrowcliffe TW
    Br J Haematol; 1989 Mar; 71(3):387-91. PubMed ID: 2495017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired cell-mediated immunity in hemophilia. II. Persistence of subclinical immunodeficiency and enhancement of natural killer activity by lymphokines.
    Lederman MM; Ratnoff OD; Schacter B; Shoger T
    J Lab Clin Med; 1985 Aug; 106(2):197-204. PubMed ID: 2410523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell sensitization to factor VIII in haemophilia A?
    Madhok R; Smith J; Jenkins A; Lowe GD
    Br J Haematol; 1991 Oct; 79(2):235-8. PubMed ID: 1958481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of lymphocyte IL2-receptor expression by factor VIII concentrate: a possible cause of immunosuppression in haemophiliacs.
    Hay CR; McEvoy P; Duggan-Keen M
    Br J Haematol; 1990 Jun; 75(2):278-81. PubMed ID: 2115376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the purification of antihemophilic factor (factor VIII). II. Separation of partially purified antihemophilic factor by gel filtration of plasma.
    Ratnoff OD; Kass L; Lang PD
    J Clin Invest; 1969 May; 48(5):957-62. PubMed ID: 5780204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.
    White GC; Greenwood R; Escobar M; Frelinger JA
    Haematologica; 2000 Oct; 85(10 Suppl):113-6. PubMed ID: 11187862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VIII concentrates and the immune system--laboratory investigations.
    Wadhwa M; Barrowcliffe TW; Mire-Sluis AR; Thorpe R
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S65-79. PubMed ID: 7495973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
    Smolen JS; Bettelheim P; Köller U; McDougal S; Graninger W; Luger TA; Knapp W; Lechner K
    J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro restoration by interleukin-2 (IL-2) of the impaired natural killer cell activities, IL-2 receptor expression, and T cell proliferation in hemophilia.
    Zaizov R; Cohen IJ; Luria D; Trainin N; Umiel T
    J Biol Response Mod; 1986 Aug; 5(4):339-50. PubMed ID: 3090209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of factor VIII, factor IX and immunoglobulin preparations on mitogen-induced lymphocyte proliferation].
    Glöckel U; Gromball J; Kobatsch B; Leppik KH; Leibold W; Beck JD
    Immun Infekt; 1987 Apr; 15(2):62-5. PubMed ID: 3110051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.
    Siegel JP; Djeu JY; Stocks NI; Masur H; Gelmann EP; Quinnan GV
    J Clin Invest; 1985 Jun; 75(6):1957-64. PubMed ID: 2989337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral-mediated suppression of interleukin 2-dependent target cell proliferation in acquired immune deficiency syndrome (AIDS): interference with normal IL-2 receptor expression.
    Donnelly RP; La Via MF; Tsang KY
    Clin Exp Immunol; 1987 Jun; 68(3):488-99. PubMed ID: 3115647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T lymphocytes from hemophiliacs proliferate after exposure to factor VIII product.
    Matheson DS; Green BJ; Poon MC; Bowen TJ; Fritzler MJ; Hoar DI
    Vox Sang; 1986; 51(2):92-5. PubMed ID: 2430365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of human T cell responses to allogeneic stimuli by factor VIII concentrates.
    Batchelor A; Steel CM; Ludlam CA
    Br J Haematol; 1992 Sep; 82(1):94-8. PubMed ID: 1419808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate?
    Froebel KS; Madhok R; Forbes CD; Lennie SE; Lowe GD; Sturrock RD
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1091-3. PubMed ID: 6226334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous production of a suppressor factor by a human macrophage-like cell line U937. II. Suppression of antigen- and mitogen-induced blastogenesis, IL 2 production and IL 2 receptor expression in T lymphocytes.
    Fujiwara H; Toossi Z; Ohnishi K; Edmonds K; Ellner JJ
    J Immunol; 1987 Jan; 138(1):197-203. PubMed ID: 3097146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of transforming growth factor-beta as a contaminant in factor VIII concentrates: a possible link with immunosuppressive effects in hemophiliacs.
    Wadhwa M; Dilger P; Tubbs J; Mire-Sluis A; Barrowcliffe T; Thorpe R
    Blood; 1994 Sep; 84(6):2021-30. PubMed ID: 8081003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.